We are live on ! Find out more
PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM

Delisted

PHXM was delisted on the 8th of March, 2024.

Back to rankings

4 hedge funds and large institutions have $7.12M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0% more ownership

Funds ownership: 4.31% → 4.31% (0%)

27% less capital invested

Capital invested by funds: $9.78M → $7.12M (-$2.66M)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PHXM Hedge Fund Activity: Q1 2020 in Review

4 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q1 2020, worth a combined $7.12M — down 27% from $9.78M a quarter earlier.

Fund positioning in PHXM was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $7.12M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q1 2020, down 27% quarter-over-quarter.
  • 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q1 2020 and 0 closed out.

Based on aggregated 13F filings for Q1 2020.